Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Role of Immunosuppressive Therapy for the Treatment of Multiple Sclerosis.
Month of birth and risk of multiple sclerosis in a Portuguese population.
Advanced MRI in multiple sclerosis: current status and future challenges.
Mapping the accumulation of co-infiltrating CNS dendritic cells and encephalitogenic T cells during EAE.
Multiple sclerosis: Interaction between IFN-β and vitamin D in modulation of MS risk.
Dengue fever in patients with multiple sclerosis taking fingolimod or natalizumab.
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy.
Diagnostic utility of NMO/AQP4-IgG in evaluating CNS inflammatory disease in Thai patients.
Autologous Mesenchymal Stem Cell Therapy in Progressive Multiple Sclerosis: an open label study.
Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades.
The Physical and Psychological Impact of Multiple Sclerosis Using the MSIS-29 via the Web Portal of the UK MS Register.
Urinary catheterization may not adversely impact quality of life in multiple sclerosis patients.
The epidemiology and pathophysiology of neurogenic bladder.
Clinical characteristics of optic neuritis in koreans greater than 50 years of age.
Circadian rhythmicity of inflammatory serum parameters: a neglected issue in the search of biomarkers in multiple sclerosis.
A microbial symbiosis factor prevents intestinal inflammatory disease.
18F-FDG PET/CT in Tumefactive Multiple Sclerosis.
MicroRNA dysregulation in multiple sclerosis.
Environmental exposures and the risk of multiple sclerosis investigated in a Norwegian case-control study.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Non-Significant Associations Between Measures of Inhibitory Control and Walking While Thinking in Persons with Multiple Sclerosis.
Cognitive correlates of under-ambiguity and under-risk decision making in high-functioning patients with relapsing remitting multiple sclerosis.
Brain reserve and cognitive reserve protect against cognitive decline over 4.5 years in MS.
Benfotiamine upregulates antioxidative system in activated BV-2 microglia cells.
Management of pain in advanced disease.

Pages